129 related articles for article (PubMed ID: 628528)
1. Stimulation of follicular growth with "pure" FSH in patients with anovulation and elevated LH levels.
Schoemaker J; Wentz AC; Jones GS; Dubin NH; Sapp KC
Obstet Gynecol; 1978 Mar; 51(3):270-7. PubMed ID: 628528
[TBL] [Abstract][Full Text] [Related]
2. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
[TBL] [Abstract][Full Text] [Related]
3. Ovulation induction with low doses of "pure" follicle stimulating hormone using a fixed protocol in patients with polycystic ovarian disease.
Bregieiro LO; de Moura MD; Ferriani RA; Bailão LA; de Sá MF
Int J Fertil Menopausal Stud; 1993; 38(3):152-9. PubMed ID: 8348163
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of different gonadotropin combinations to support ovulation induction in WHO type I anovulation infertility: clinical evidences of human recombinant FSH/human recombinant LH in a 2:1 ratio and highly purified human menopausal gonadotropin stimulation protocols.
Carone D; Caropreso C; Vitti A; Chiappetta R
J Endocrinol Invest; 2012 Dec; 35(11):996-1002. PubMed ID: 23095369
[TBL] [Abstract][Full Text] [Related]
6. Ovulation induction in clomiphene-resistant anovulatory women: differential follicular response to purified urinary follicle-stimulating hormone (FSH) versus purified urinary FSH and luteinizing hormone.
Hoffman DI; Lobo RA; Campeau JD; Tsai HM; Holmberg EA; Ono T; Frederick JJ; Platt LD; diZerega GS
J Clin Endocrinol Metab; 1985 May; 60(5):922-7. PubMed ID: 3920235
[TBL] [Abstract][Full Text] [Related]
7. The role of chronic anovulation in the polycystic ovary syndrome: normalization of sex-hormone-binding globulin levels after clomiphene-induced ovulation.
Eden JA; Place J; Carter GD; Alaghband-Zadeh J; Pawson ME
Clin Endocrinol (Oxf); 1989 Mar; 30(3):323-32. PubMed ID: 2512039
[TBL] [Abstract][Full Text] [Related]
8. Ovulation induction with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression by gonadotropin releasing hormone agonist in polycystic ovary disease. A cross-over study.
Fulghesu AM; Lanzone A; Guida C; Nicoletti MC; Rossi P; Le Donne M; Caruso A; Mancuso S
J Reprod Med; 1992 Oct; 37(10):834-40. PubMed ID: 1479563
[TBL] [Abstract][Full Text] [Related]
9. Plasma hormones in human gonadotropin induced ovulation.
Wu CH
Obstet Gynecol; 1977 Mar; 49(3):308-13. PubMed ID: 840459
[TBL] [Abstract][Full Text] [Related]
10. The step-down principle in gonadotrophin treatment and the role of GnRH analogues.
Fauser BC; Donderwinkel P; Schoot DC
Baillieres Clin Obstet Gynaecol; 1993 Jun; 7(2):309-30. PubMed ID: 8358893
[TBL] [Abstract][Full Text] [Related]
11. Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation.
Anderson RA; Groome NP; Baird DT
Clin Endocrinol (Oxf); 1998 May; 48(5):577-84. PubMed ID: 9666869
[TBL] [Abstract][Full Text] [Related]
12. Hypothalmic-pituitary relationships in the polycystic ovary syndrome serum gonadotrophin levels following injection of oestradiol benzoate.
Shaw RW; Duignan NM; Butt WR; Edwards RL; London DR
Br J Obstet Gynaecol; 1975 Dec; 82(12):952-7. PubMed ID: 1106757
[TBL] [Abstract][Full Text] [Related]
13. Induction of ovulation in polycystic ovary: human menopausal gonadotropin or human urinary follicle stimulating hormone?
Venturoli S; Paradisi R; Fabbri R; Porcu E; Orsini LF; Flamigni C
Int J Fertil; 1987; 32(1):66-70. PubMed ID: 2880819
[TBL] [Abstract][Full Text] [Related]
14. [Induction of follicle maturation with "pure" FSH in polycystic ovary syndrome].
Birkhäuser MH; Huber PR; Neuenschwander E; Näpflin S
Geburtshilfe Frauenheilkd; 1988 Apr; 48(4):220-7. PubMed ID: 3132413
[TBL] [Abstract][Full Text] [Related]
15. Ovulation of a single dominant follicle during treatment with low-dose pulsatile follicle stimulating hormone in women with polycystic ovary syndrome.
Polson DW; Mason HD; Saldahna MB; Franks S
Clin Endocrinol (Oxf); 1987 Feb; 26(2):205-12. PubMed ID: 3117445
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and endocrinologic aspects of treatment with pure FSH. A report of experiences].
Graf M; Freundl G
Zentralbl Gynakol; 1990; 112(2):81-90. PubMed ID: 2107649
[TBL] [Abstract][Full Text] [Related]
17. Effect of celioscopic ovarian resection in patients with polycystic ovaries.
Campo S; Garcea N; Caruso A; Siccardi P
Gynecol Obstet Invest; 1983; 15(4):213-22. PubMed ID: 6220946
[TBL] [Abstract][Full Text] [Related]
18. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
19. Early prediction of ovarian multifollicular response during ovulation induction in patients with polycystic ovary syndrome.
Farhi J; Jacobs HS
Fertil Steril; 1997 Mar; 67(3):459-62. PubMed ID: 9091330
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. The European Recombinant Human LH Study Group.
J Clin Endocrinol Metab; 1998 May; 83(5):1507-14. PubMed ID: 9589647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]